Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Raymond James Financial, Inc. Common Stock (NY:RJF)

169.15 +0.12 (+0.07%)
Streaming Delayed Price Updated: 10:25 AM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Raymond James Financial, Inc. Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
News headline image
Intel stock: Analysts are expecting multi-year highs
It will be a while before Intel is a serious threat to the likes of Nvidia, but that doesn't mean there's not a ton of opportunity still to be had right now. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Should You Buy Stocks If a Recession Is Coming in 2024? Here's What History Shows. ↗
Recessions can present great buying opportunities for long-term investors. 
Via The Motley Fool
Topics Economy
News headline image
Raymond James Maintains Outperform Rating for Centerra Gold: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Racing For GenAI Dominance: 2024 Competition Intensifies, Here Are 3 Likely Winners ↗
In 2024, the race for generative AI dominance intensifies, analyst predicts. These key players will shape the future. 
Via Benzinga
Topics Artificial Intelligence
News headline image
There Is More Value In The Financial Sector Than Any Other Sector ↗
Thanks to the great recession of 2008 and 2009, there is more value to be found in the financial sector than any other of the 11 sectors. 
Via Talk Markets
Topics Economy
News headline image
What To Know About Raymond James's Upgrade of AutoZone ↗
 
Via Benzinga
News headline image
Earnings Scheduled For October 25, 2023 ↗
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
News headline image
Raymond James Maintains Strong Buy Rating for Blueprint Medicines: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Strong Buy Rating for EOG Resources: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Cybersecurity Stocks: Palo Alto Downgraded; Wedbush Hikes Price Targets ↗
Raymond James downgraded Palo Alto Networks on Monday while Wedbush raised its price targets on PANW stock and a few other companies. 
Via Investor's Business Daily
News headline image
Raymond James Maintains Strong Buy Rating for Construction Partners: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Financial Raises Quarterly Dividends on Common Stock; Increases Common Stock Repurchase Authorization
From Raymond James Financial
Via GlobeNewswire
News headline image
Raymond James Maintains Outperform Rating for Micron Technology: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Strong Buy Rating for Redwood Trust: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for MFA Finl: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for Global E Online: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Katipult Launches Automated Investor Marketing Solution for Investment Dealers
Calgary, Alberta--(Newsfile Corp. - November 16, 2023) - Katipult Technology Corp. (TSXV: FUND) ("Katipult" or the "Corporation"), a leading Fintech... 
Via Newsfile
News headline image
Raymond James Maintains Outperform Rating for Leap Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for WhiteHorse Finance: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for PubMatic: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Strong Buy Rating for CymaBay Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Strong Buy Rating for Cognex: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Secret Tops - A Brief Look At Some Gems ↗
I recently thumbed through the tagged items in my watch list which have enticing tops but haven’t quite made the cut since they are relatively thinly-traded. It’s still worth a look, however, because... 
Via Talk Markets
News headline image
Wall Street Thinks This Ultra-High-Yield Dividend Stock Down Nearly 30% This Year Is a Screaming Buy ↗
This beaten-down oil stock looks like a bargain. 
Via The Motley Fool
News headline image
Raymond James Maintains Strong Buy Rating for Brinker International: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for Neurocrine Biosciences: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Maintains Outperform Rating for NOV: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Raymond James Financial Reports Fiscal Fourth Quarter and Fiscal 2023 Results
From Raymond James Financial
Via GlobeNewswire
News headline image
Raymond James Maintains Outperform Rating for LianBio: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
IBD's 100 Best ESG Companies For 2023 ↗
The companies on our list combine high sustainability scores and top stock ratings. 
Via Investor's Business Daily
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.